CHL1 and breast cancer: We also demonstrated that CHL1 hypermethylation can be reversed by epigenetic treatment, since demethylating agents and histone deacetylase inhibitors modulated dynamics of CHL1 expression in vitro and restored its silenced status in BC-derived cell lines.